Arbutus Biopharma (ABUS) Stock Price & Analysis

ABUS$4.09+0.06 +1.49%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$626.97MEnterprise value$546.39MRevenue (TTM)$181.49MMarket position—

Score

81
Bullish
Value
64
Quality
79
Growth
100

AI Analysis

Snapshot

Arbutus Biopharma mixes growth with a still-reasonable multiple — Growth 100/100 with P/E 3.6. Under the hood: P/E 3.6, plus latest revenue up ~128% YoY.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

64
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

79
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Arbutus Biopharma Corp (ABUS) last printed $4.09. Equity value is $626.97M. Trailing earnings multiple 2.85. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$1.5M$10.7M$5.9M$6.01M$6.91M$10.99M$39.02M$18.14M$6.17M$14.08M

About

Company description is not on file.

Arbutus Biopharma (ABUS) Stock Price & Analysis

ABUS price $4.09 +0.06 +1.49%

Ticker
ABUS
Price
$4.09
Change
+0.06 +1.49%
Market cap
$626.97M
P/E
2.85
Forward P/E
5.78
Dividend yield
0.00%
Beta
0.62
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
81
Value
64
Quality
79
Growth
100

Stocklytics score rationale: value 64, quality 79, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener